We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
Cap. Flow
+$224M
Cap. Flow %
1.06%
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$211M
2
ABBV icon
AbbVie
ABBV
+$176M
3
AAPL icon
Apple
AAPL
+$170M
4
NKE icon
Nike
NKE
+$161M
5
KO icon
Coca-Cola
KO
+$141M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$221M
2
MDT icon
Medtronic
MDT
+$163M
3
UNH icon
UnitedHealth
UNH
+$148M
4
JNJ icon
Johnson & Johnson
JNJ
+$133M
5
PFE icon
Pfizer
PFE
+$126M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 14.98%
3 Healthcare 13.91%
4 Financials 10.93%
5 Industrials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XM
1626
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-281,182
Closed -$5.01M
RXDX
1627
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
-179,285
Closed -$19.2M
MGI
1628
DELISTED
MoneyGram International, Inc. New
MGI
-989,906
Closed -$10.3M
MNTV
1629
DELISTED
Momentive Global Inc. Common Stock
MNTV
-165,682
Closed -$1.54M
AQUA
1630
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
-4,563
Closed -$227K
ABB
1631
DELISTED
ABB Ltd
ABB
-453,522
Closed -$15.6M
SUMO
1632
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-147,073
Closed -$1.76M
PRVB
1633
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-499,080
Closed -$12M
CSII
1634
DELISTED
Cardiovascular Systems, Inc.
CSII
-18,304
Closed -$364K
APEN
1635
DELISTED
Apollo Endosurgery, Inc.
APEN
-21,770
Closed -$216K
SJR
1636
DELISTED
Shaw Communications Inc.
SJR
-337,197
Closed -$10.1M
EBIX
1637
DELISTED
Ebix Inc
EBIX
-25,839
Closed -$341K
HSKA
1638
DELISTED
Heska Corp
HSKA
-25,196
Closed -$2.46M
INBX
1639
DELISTED
Inhibrx, Inc. Common Stock
INBX
-92,107
Closed -$1.74M

Similar funds

Voloridge Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
  • Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
  • Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
  • Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
  • Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
  • Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
  • Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.